News
-
NewsNew guidance published on eating-disorder-related medical emergencies
New RCP guidance covers the recognition and management of medical emergencies in eating disorders, as hospitalisations rise significantly
-
News
Four more monkeypox cases in UK bring total to seven
The UK Health Security Agency (UKHSA) has announced a further four cases of monkeypox in the UK
-
News
NICE recommends combination drug for women with uterine fibroids
Approximately 4500 women with uterine fibroids will be eligible to receive the drug
-
News
NHS staffing should pre-empt the changing medical needs of the UK
NHS staffing and training need to be more ‘fluid’ in response to the health needs of the nation, said a speaker at a meeting of the Health and Social Care Committee on 11 May
-
News
GPs only refer one in 33 people eligible for weight-management programmes
Eligible young White men are the least likely to be referred for weight-management programmes, researchers have found
-
News
Fourth mRNA vaccine dose shown to give ‘substantial’ immunity boost
A new study from the COV-BOOST trial has found that a fourth dose of a COVID-19 vaccine provides a substantial boost to both antibody and cellular immunity
-
News
Mental Health Awareness Week 2022: loneliness
Taking place from 9 to 15 May, the focus this year is on raising awareness of the impact of loneliness on our mental health and the practical steps we can take to address it
-
News
WHO publishes a global report on infection prevention and control
The report gives a situation analysis of IPC programmes across the world, including data from recent World Health Organization research
-
News
Life-saving COVID-19 treatment rolled out by NHS
A life-saving drug, typically used to treat arthritis, is now available to treat hospitalised COVID-19 patients
-
News
Severe COVID-19 can cause lasting cognitive and mental health problems
A new study has reported that cognitive impairment from severe COVID-19 is equivalent to 20 years of ageing
-
News
Researchers find treatment for early stage Dupuytren’s disease
A phase-2b trial has shown the effectiveness of an anti-tumour necrosis factor drug for treating the disease at an early stage
-
News
Emergency measures in place over HRT shortages
The Government has promised action to address supply chain problems that have led to rationing of three HRT products
-
News
GINA updates its asthma report for 2022
The most recent update to GINA’s asthma report contains new advice about COVID-19 and asthma, as well as changes to LAMA recommendations
-
News
Only one in four feel fully recovered following COVID-19 hospitalisation
Being female, obese, and having had mechanical ventilation in hospital are all associated with being less likely to feel fully recovered 1 year after COVID-19 hospitalisation
-
News
Modern slavery ban on NHS supplies set to become law
MPs continue to debate an amendment to the Health and Care Bill that would help prevent goods and services associated with modern slavery and human trafficking from entering the supply chain
-
News
MHRA calls for views on making overactive bladder treatment available without prescription
The MHRA has opened a consultation to make oxybutynin hydrochloride tablets, used for the treatment of overactive bladder, available without prescription
-
News
More cases of hepatitis identified in UK children
Investigations of a spike in hepatitis cases in children continue to point to adenovirus infection, but COVID-19 has not been ruled out as a contributing factor
-
News
Safety study on risks of using pregabalin during pregnancy
A new study has suggested pregabalin may slightly increase the risk of major congenital malformations if used in pregnancy
-
News
UKHSA advises GP practices to end physical distancing measures
The UK Health Security Agency has updated its infection prevention and control guidance, suggesting a return to ‘pre-pandemic physical distancing in all areas’
-
News
Valneva’s COVID-19 vaccine has been granted UK regulatory approval
The VLA2001 vaccine developed by French firm Valneva becomes the sixth COVID-19 vaccine to be granted regulatory approval in the UK
